Phase I/II trial of twice-daily temozolomide and celecoxib for treatment of relapsed malignant glioma: Final data

Phase I/II trial of twice-daily temozolomide and celecoxib for treatment of relapsed malignant glioma: Final data S. C. Pannullo, J. Burton, J. Serventi, P. Stieg, H. Subramanian, R. Elsoueidi, I. El-Jassous and C. Balmaceda Staten Island University Hospital, Staten Island, NY; New York Presbyterian Hospital-Weill Cornell University, New York, NY; J.F.K. Medical Center, Edison, NJ; New York Presbyterian Hospital-Columbia, New York, NY